These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12159894)

  • 21. Brightening up: the effect of the Physician Payment Sunshine Act on existing regulation of pharmaceutical marketing.
    Gorlach I; Pham-Kanter G
    J Law Med Ethics; 2013; 41(1):315-22. PubMed ID: 23581674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pens.
    Silverberg NB
    Cutis; 2009 Dec; 84(6):291. PubMed ID: 20166568
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
    Berger JT
    Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
    [No Abstract]   [Full Text] [Related]  

  • 25. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1193-6. PubMed ID: 12775622
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota.
    Ross JS; Lackner JE; Lurie P; Gross CP; Wolfe S; Krumholz HM
    JAMA; 2007 Mar; 297(11):1216-23. PubMed ID: 17374816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lunch with Lilly: who pays?
    Strong C
    Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
    [No Abstract]   [Full Text] [Related]  

  • 28. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 29. Proposed guidelines for speakers discussing medications and other products.
    Daniel CR; Elewski BE; Scher RK
    Cutis; 1997 May; 59(5):271-2. PubMed ID: 9169269
    [No Abstract]   [Full Text] [Related]  

  • 30. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 31. The death of common sense.
    Trachtman H
    Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
    [No Abstract]   [Full Text] [Related]  

  • 32. All rationalizations large and small.
    Goodman B
    Am J Bioeth; 2003; 3(3):57-8. PubMed ID: 14594496
    [No Abstract]   [Full Text] [Related]  

  • 33. Updated estimates of pharmaceutical company payments to physicians in Vermont.
    Ross JS; Nazem AG; Lurie P; Lackner JE; Krumholz HM
    JAMA; 2008 Nov; 300(17):1998-2000. PubMed ID: 18984886
    [No Abstract]   [Full Text] [Related]  

  • 34. Disclosure of industry payments to physicians.
    Steinbrook R
    N Engl J Med; 2008 Aug; 359(6):559-61. PubMed ID: 18687636
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug companies and clinical psychology.
    Baker E; Newnes C; Myatt H
    Ethical Hum Sci Serv; 2003; 5(3):247-53. PubMed ID: 15139338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-tech stealth being used to sway doctor prescriptions.
    Stolberg SG; Gerth J
    N Y Times Web; 2000 Nov; ():A1, A22. PubMed ID: 12159839
    [No Abstract]   [Full Text] [Related]  

  • 37. MSJAMA: gifts to physicians in the consumer marketing era.
    Steinman MA
    JAMA; 2000 Nov; 284(17):2243. PubMed ID: 11056602
    [No Abstract]   [Full Text] [Related]  

  • 38. Stanford to ban drug makers' gifts to doctors, even pens.
    Pollack A
    N Y Times Web; 2006 Sep; ():C2. PubMed ID: 16972375
    [No Abstract]   [Full Text] [Related]  

  • 39. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where marketing and medicine meet.
    Kolata G
    N Y Times Web; 1998 Feb; ():A14. PubMed ID: 11647547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.